Pegylated interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4 in adolescents

Annals of Hepatology

Volumn 9, Issue 2, 2010, Pages 156-160

  Ali, Jaber Al ^a   Owayed, Salem ^a   Al Qabandi, Wafa'a ^c   Husain, Khaled ^b   Hasan, Fuad ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

^b AL AMIRI HOSPITAL   (Kuwait)

^c AL ADAN HOSPITAL   (Kuwait)

Author keywords

Adolescents; Chronic Hepatitis C Virus; Genotype; Peginterferon Alpha 2b

Indexed keywords

PEGATRON; PEGINTERFERON ALPHA2B; RIBAVIRIN; UNCLASSIFIED DRUG; ALPHA2B INTERFERON; ANTIVIRUS AGENT; MACROGOL DERIVATIVE; PEGINTERFERON ALFA-2B;

ADOLESCENT; ANEMIA; ARTICLE; CLINICAL ARTICLE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FLU LIKE SYNDROME; GENOTYPE; HEPATITIS C; HUMAN; HUMAN TISSUE; HYPOTHYROIDISM; INSOMNIA; INSULIN DEPENDENT DIABETES MELLITUS; LIVER BIOPSY; MENORRHAGIA; MYALGIA; NEUTROPENIA; OPEN STUDY; PATIENT COMPLIANCE; PILOT STUDY; TREATMENT DURATION; TREATMENT RESPONSE; AGE; BIOPSY; DRUG COMBINATION; GENETICS; HEPATITIS C VIRUS; KUWAIT; MALE; TIME; TREATMENT OUTCOME;

ADOLESCENT; AGE FACTORS; ANTIVIRAL AGENTS; BIOPSY; DRUG THERAPY, COMBINATION; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; KUWAIT; MALE; PILOT PROJECTS; POLYETHYLENE GLYCOLS; RIBAVIRIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 77956641347     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31654-0     Document Type: Article

References (26)

1. Abdel-Aziz F, Habib M, Mohamed MK, Abdel-Hamid M, Gamil F, Madkour S, Mikhail NN, et al. Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence. Hepatology 2000; 32: 111-5.
2. Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL. Genetic epidemiology of hepatitis C virus throughout Egypt. J Infect Dis 2000; 182:698-707.
3. Angelico M, Renganathan E, Gandin C, Fathy M, Profili MC, Refai W, De Santis A, Nagi A, et al. Chronic liver disease inthe Alexandria governorate, Egypt, contribution of schistosomiasis and hepatitis virus infections. J Hepatololgy 1997; 26: 236-43.
4. Bortolotti F, Verucchi G, Camma C, Cabibbo G, Zancan L, Indolfi G, Giacchino R, et al. Italian Observatory for HCV Infection and Hepatitis C in Children. Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. Gastroenterology 2008; 134: 1900-7.
5. Lai ME, De Virgilis S, Argiolu F, Farci P, Mazzoleni AP, Lisci V, Rapicetta M, et al. Evaluation of antibodies to hepatitis C virus in a long-term prospective study of posttransfusion hepatitis among thalassemic children: comparison between first-and second-generation assay. J Pediatr Gastroenterol Nutr 1993; 16: 458-64.
6. Jonas MM. Children with hepatitis C. Hepatology 2002; 36: S173-8.
7. Gonzalez-Peralta RP, Kelly DA, Haber B, Molleston J, Murray KF, Jonas MM, Shelton M, et al. International Pediatric Hepatitis C Therapy Group. Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics. Hepatology 2005; 42: 1010-8.
8. Wirth S, Lang T, Gerner P, Gehring S. Interferon-alpha and ribavirin treatment in children and adolescents with chronic hepatitis C. Hepatology 2002; 36: 1280-4.
9. Jacobson KR, Murray K, Zellos A, Schwarz KB. An analysis of published trials of interferon monotherapy in children with chronic hepatitis C. J Pediatr Gastroenterol Nutr 2002 Jan; 34(1): 52-8.
10. Schwarz KB, Mohan P, Narkewicz MR, et al. Safety, efficacy and pharmacokinetics of peginterferon alpha2a (40 kd) in children with chronic hepatitis C. J Pediatr Gastroenterol Nutr 2006 Oct; 43(4): 499-505.
11. Wirth S, Pieper-Boustani H, Lang T, et al. Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C. Hepatology 2005; 41: 1013-18.
12. Baker RD, Dee D, Baker SS. Response to pegylated interferon alpha-2b and ribavirin in children with chronic hepatitis C. J Clin Gastroenterol 2007 Jan; 41(1): 111-14.
13. Wirth S, Ribes-Koninckx C, Calzado MA, et al. High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin. J Hepatol 2010 Feb 4. In press.
14. Hassan F, Asker H, Al-Khaldi J, et al. Peginterferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4. Am J Gastroenterol 2004; 99: 1733-7.
15. Kamal S, El Tawail AA, Nakano T, et al. Peginterferon alpha 2b and ribavirin therapy in chronic hepatitis C genotype 4: impact of treatment duration and viral kinetics on sustained virologic response. Gut 2005; 54: 858-66.
16. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347: 975-82.
17. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet 2001; 358: 958-65.
18. Hadziyannis SJ, Sette H Jr, Morgan TR, et al. Peginter-feron-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 2004; 140: 346-55.
19. Bortolotti F, Giacchino R, Vajro P, Barbera C, Crivellaro C, Alberti A, Nebbia G, et al. Recombinant interferon-alfa therapy in children with chronic hepatitis C. Hepatology 1995; 22: 1623-7.
20. Marcellini M, Kondili LA, Comparcola D, Spada E, Sartorelli MR, Palumbo M, Rapicetta M. High dosage alpha-interfe-ron for treatment of children and young adults with chronic hepatitis C disease. Pediatr Infect Dis J 1997; 16: 1049-53.
21. Christensson B, Wiebe T, Akesson A, Widell A. Interferon-alfa and ribavirin treatment of hepatitis C in children with malignancy in remission. Clin Infect Dis 2000; 30: 585-6.
22. Lackner H, Moser A, Deutsch J, Kessler HH, Benesch M, Kerbl R, et al. Interferon-alpha and ribavirin in treating children and young adults with chronic hepatitis C after malignancy. Pediatrics 2000; 106: E53.
23. Kelly DA, Bunn SK, Apelian D, Baczkowski A, Gupta S, Laug-hlin M, et al. Safety, efficacy, and pharmacokinetics of interferon alfa-2b plus ribavirin in children with chronic hepatitis C. Hepatology 2001; 34: 342A.
24. Su'oglu O D, Elkabes B, Sokucu S, Saner G. Does interferon and ribavirin combination therapy increase the rate of treatment response in children with hepatitis C. J Pediatr Gastroenterol Nutr 2002; 34: 199-206.
25. Figlerowicz M, Sluzewski W, Koala-Piaskowska A, Mozer-Li-sewska I. Interferon alpha and ribavirin in the treatment of children with chronic hepatitis C. Eur J Pediatr 2004; 163: 265-7.
26. Jara P, Hierro L. Treatment of hepatitis C in children. Expert Rev Gastroenterol Hepatol 2010 Feb; 4(1): 51-61. (In press).